These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 471318)

  • 1. [Urinary kallikrein excretion in normal subjects and in patients with essential hypertension].
    Pierucci A; Cinotti GA; Simonetti BM; Taggi F; Ronci R; Raganelli L; Stirati G
    Minerva Nefrol; 1979; 26(1):19-23. PubMed ID: 471318
    [No Abstract]   [Full Text] [Related]  

  • 2. [Salt-dependence of blood pressure and urinary kallikrein excretion in essential hypertension (author's transl)].
    Kojima S; Ito K; Sakaguchi A; Kimura G; Uda M; Kuroda K; Natsume T; Sakamoto N; Tsuchiya M; Tanaka T; Satani M; Ikeda M
    Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1105-12. PubMed ID: 6915133
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ; Fitz AE
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary kallikrein excretion in primary arterial hypertension].
    Majewska Z
    Kardiol Pol; 1981; 24(10):657-64. PubMed ID: 7035733
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary kallikrein and plasma renin levels in patients with secondary hypertension].
    Giermakowska-Kowalik T; Kuska J; Kokot F
    Pol Tyg Lek; 1984 Mar; 39(10):325-8. PubMed ID: 6382209
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the changes in urinary kallikrein excretion on altering sodium intake an index of salt sensitivity?
    Blackwood AM; Inoue J; Sagnella GA; Miller MA; Markandu ND; MacGregor GA
    J Hum Hypertens; 1994 Aug; 8(8):619-21. PubMed ID: 7990095
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
    Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin, kallikrein and prostaglandin renal systems in normotensive boys with and without a family history of essential hypertension.
    Rey C; Santos F; Málaga S; Orejas G; Simarro M; Crespo M
    J Cardiovasc Risk; 1995 Apr; 2(2):143-8. PubMed ID: 7606651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma bradykinin levels and urinary kallikrein excretion in normal renin essential hypertension.
    Mersey JH; Williams GH; Emanuel R; Dluhy RG; Wong PY; Moore TJ
    J Clin Endocrinol Metab; 1979 Apr; 48(4):642-7. PubMed ID: 429510
    [No Abstract]   [Full Text] [Related]  

  • 11. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
    Johnston CI; Matthews PG; Dax E
    Clin Sci Mol Med Suppl; 1976 Dec; 3():283s-286s. PubMed ID: 1071628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive humoral systems and sodium transport in erythrocytes of normotensive offsprings of essential hypertensive subjects.
    Janata V; Bultasová H; Pinsker P
    Physiol Bohemoslov; 1990; 39(1):65-70. PubMed ID: 2142790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
    Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical biochemical and haemodynamic correlates of sodium sensitivity in essential hypertension.
    Koolen MI; Bussemaker-Verduyn den Boer E; van Brummelen P
    J Hypertens Suppl; 1983 Dec; 1(2):21-3. PubMed ID: 6400114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of salt intake on endothelium-derived factors in a group of patients with essential hypertension.
    Bragulat E; de la Sierra A; Antonio MT; Jiménez W; Urbano-Márquez A ; Coca A
    Clin Sci (Lond); 2001 Jul; 101(1):73-8. PubMed ID: 11410117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal kallikrein-kinin, prostaglandin E2, and dopamine systems in young normotensive subjects with a family history of essential hypertension.
    Shimamoto K; Ura N; Nishimura M; Iimura O
    Am J Med Sci; 1994 Feb; 307 Suppl 1():S70-4. PubMed ID: 8141169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary excretion of kallikrein and prostaglandins before and after sodium deprivation and their relationships to plasma vasopressive substances].
    Nigawara K; Kawaguchi T; Yanagiya H; Toda T; Suzuki T; Funyu T; Terayama Y; Yamaya K; Igarashi R
    Nihon Jinzo Gakkai Shi; 1987 Oct; 29(10):1215-22. PubMed ID: 3326953
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism.
    Lechi A; Covi G; Lechi C; Corgnati A; Arosio E; Zatti M; Scuro LA
    Clin Sci Mol Med; 1978 Jul; 55(1):51-5. PubMed ID: 668267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of renin-angiotensin system activation by dietary sodium restriction and upright position on plasma leptin concentration in patients with essential hypertension.
    Adamczak M; Kokot F; Chudek J; Wiecek A
    Med Sci Monit; 2002 Jul; 8(7):CR473-7. PubMed ID: 12118193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.